New combo therapy shows promise for tough lung cancer
NCT ID NCT05348668
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 28 times
Summary
This study tested a new way of giving radiation therapy (hybrid dose-fraction radiotherapy) along with immunotherapy for people with advanced non-small cell lung cancer that has spread. The goal was to see if this combination is safe and can help control the cancer longer. 78 adults aged 18-75 with stage IV lung cancer took part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Anhui Provicial Hospital
Hefei, Anhui, China
Conditions
Explore the condition pages connected to this study.